Why retinoic acid is effective in this setting but not against primary tumors, has been speculated about for nearly 50 years. Scientists resolved the mystery, showing the drug ‘hijacks’ a normal developmental pathway to trigger cancer cell death.
Scientists solve mystery of how the drug retinoic acid works to treat neuroblastoma
